Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 99.7% | 337.13 g·mol⁻¹ | C13H9BrN2O4 | 10 MG
SDP

Catalog No. 5000299757
Encompass_Preferred

Thalidomide-4-Br is a brominated derivative of thalidomide that acts as a small-molecule bromodomain probe. It is provided as a high-purity solid for in vitro and preclinical research in inflammation, oncology, and neurology.

  • Bromodomain-containing small molecule probe.
  • Suitable for inflammation, tumor, and neurology research.
  • High purity: 99.7%.
  • Molecular formula C13H9BrN2O4; molecular weight 337.13 g·mol⁻¹.
  • Available in multiple pack sizes including 10 mg.
  • Powder storage: -20°C (3 years) or 4°C (2 years).

Catalog No. 50-002-99757 Supplier Medchemexpress LLC Supplier No. HYW03911610MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-4-Br is a brominated derivative of thalidomide that acts as a small-molecule bromodomain probe. It is provided as a high-purity solid for in vitro and preclinical research in inflammation, oncology, and neurology.

  • Bromodomain-containing small molecule probe.
  • Suitable for inflammation, tumor, and neurology research.
  • High purity: 99.7%.
  • Molecular formula C13H9BrN2O4; molecular weight 337.13 g·mol⁻¹.
  • Available in multiple pack sizes including 10 mg.
  • Powder storage: -20°C (3 years) or 4°C (2 years).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.